摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(8R,9R,10R,13S,14S)-17-methoxy-10-(methoxymethyl)-13-methyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one

中文名称
——
中文别名
——
英文名称
(8R,9R,10R,13S,14S)-17-methoxy-10-(methoxymethyl)-13-methyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one
英文别名
——
(8R,9R,10R,13S,14S)-17-methoxy-10-(methoxymethyl)-13-methyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one化学式
CAS
——
化学式
C21H34O3
mdl
——
分子量
334.5
InChiKey
WSVAKDMFKLSVME-XKEOIGLMSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.5
  • 重原子数:
    24
  • 可旋转键数:
    3
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.95
  • 拓扑面积:
    35.5
  • 氢给体数:
    0
  • 氢受体数:
    3

文献信息

  • NEUROACTIVE 19-ALKOXY-17-SUBSTITUTED STEROIDS, PRODRUGS THEREOF, AND METHODS OF TREATMENT USING SAME
    申请人:Sage Therapeutics, Inc.
    公开号:US20140235600A1
    公开(公告)日:2014-08-21
    The present disclosure is generally directed to neuroactive 19-alkoxy-17-substituted steroids as referenced herein, and pharmaceutically acceptable salts thereof, for use as, for example, an anesthetic, and/or in the treatment of disorders relating to GABA function and activity. The present disclosure is further directed to pharmaceutical compositions comprising such compounds.
    本公开涉及神经活性的19-烷氧基-17-取代类固醇,以及其药学上可接受的盐,例如用作麻醉剂和/或治疗与GABA功能和活性有关的疾病。本公开还涉及包含这些化合物的制药组合物。
  • Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same
    申请人:Washington University
    公开号:US10342809B2
    公开(公告)日:2019-07-09
    The present disclosure is generally directed to neuroactive 19-alkoxy-17-substituted steroids as referenced herein, and pharmaceutically acceptable salts thereof, for use as, for example, an anesthetic, and/or in the treatment of disorders relating to GABA function and activity. The present disclosure is further directed to pharmaceutical compositions comprising such compounds.
    本公开总体上涉及本文提及的神经活性 19-烷氧基-17-取代类固醇及其药学上可接受的盐类,用于例如麻醉剂和/或治疗与 GABA 功能和活性有关的疾病。本公开进一步涉及包含此类化合物的药物组合物。
  • NEUROACTIVE 19-ALKOXY-17-SUBSTITUTED STEROIDS, USEFUL IN METHODS OF TREATMENT
    申请人:Washington University
    公开号:EP2935307B1
    公开(公告)日:2018-04-25
  • US9630986B2
    申请人:——
    公开号:US9630986B2
    公开(公告)日:2017-04-25
  • US9676812B2
    申请人:——
    公开号:US9676812B2
    公开(公告)日:2017-06-13
查看更多